Sutro Biopharma, Inc.
STRO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001382101
No open-market purchases or sales by Sutro Biopharma, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $545.7M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Sutro Biopharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 120 | 117 | −3 |
| Shares | 39.8M | 39.9M | +27.5K (+0.1%) |
| Value | $752.5M | $593.2M | −$159.4M (−21.2%) |
New holders (14)
Institutions that held Sutro Biopharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Endurant Capital Management LP | 111,803 | $1.66M | 0.45% |
| Walleye Capital LLC | 75,412 | $1.12M | 0.04% |
| Gsa Capital Partners LLP | 71,412 | $1.06M | 0.13% |
| Renaissance Technologies LLC | 48,700 | $725.0K | 0.00% |
| HRT Financial LP | 39,377 | $585.0K | 0.00% |
| Connective Portfolio Management, LLC | 35,000 | $527.0K | 0.93% |
| Allspring Global Investments Holdings, LLC | 34,902 | $519.0K | 0.00% |
| Martingale Asset Management L P | 30,617 | $457.0K | 0.01% |
| Ergoteles LLC | 16,015 | $238.0K | 0.01% |
| Trexquant Investment LP | 14,041 | $209.0K | 0.01% |
| Qube Research & Technologies Ltd | 10,092 | $150.0K | 0.00% |
| Jefferies Group LLC | 3,400 | $50.6K | 0.00% |
| Washington Trust Advisors, Inc. | 179 | $3.00K | 0.00% |
| CWM, LLC | 24 | $0 | 0.00% |
Sold out (17)
Institutions that held Sutro Biopharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 375,000 | $7.08M |
| Woodline Partners LP | 219,511 | $4.15M |
| Ikarian Capital, LLC | 134,575 | $2.54M |
| Massachusetts Financial Services Co | 91,798 | $1.73M |
| AlphaCentric Advisors LLC | 26,000 | $491.0K |
| Boothbay Fund Management, LLC | 25,711 | $486.0K |
| J. Goldman & Co LP | 23,227 | $439.0K |
| AQR Capital Management LLC | 14,519 | $274.0K |
| Bailard, Inc. | 11,300 | $213.0K |
| DekaBank Deutsche Girozentrale | 11,000 | $201.0K |
| Cubist Systematic Strategies, LLC | 5,513 | $104.0K |
| Meeder Asset Management Inc | 3,609 | $68.0K |
| Lazard Asset Management LLC | 2,795 | $52.0K |
| Point72 Hong Kong Ltd | 1,329 | $25.0K |
| UBS Group AG | 1,221 | $23.0K |
| Penserra Capital Management LLC | 1,055 | $19.0K |
| TCI Wealth Advisors, Inc. | 169 | $3.00K |